OBJECTIVE: Sufferers with nasopharyngeal carcinoma encounter highly variable results in spite of receiving similar restorative regimens. the reduced cystatin C group, the high cystatin C group experienced considerably shorter overall success (hazard percentage=1.47, Woman2.48(1.63-3.79) 0.0011.67(1.19-2.33)0.0031.05(0.73-1.53)0.7790.93(0.60-1.47)0.77Age (years)?51 511.55(1.14-2.10)0.0050.95(0.73-1.24)0.7151.19(0.86-1.66)0.3020.56(0.36-0.85)0.007Smoking position?Ever By no means1.58(1.17-2.12)0.0031.27(0.98-1.66)0.0740.998(0.72-1.39)0.9921.01(0.66-1.54)0.97Histological type (WHO)?Type III type I-II0.95(0.49-1.86)0.880.99(0.54-1.81)0.973.76(0.93-15.20)0.0630.74(0.32-1.68)0.47Stage?III-IV I-II2.55(1.52-4.26) 0.0011.55(1.06-2.26)0.0250.91(0.61-1.36)0.6291.22(0.70-2.13)0.48Treatment?CRT RT1.64(1.14-2.35)0.0081.84(1.32-2.58) 0.0010.95(0.66-1.37)0.7851.72(1.01-2.92)0.044CysC level (mg/L)?0.945 0.9451.79(1.22-2.61)0.0031.67(1.18-2.35)0.0042.37(1.58-3.55) 0.0012.06(1.19-3.58)0.01 Open… Continue reading OBJECTIVE: Sufferers with nasopharyngeal carcinoma encounter highly variable results in spite